for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Luye Pharma Group Gets Approval For Initiating Clinical Trial For Denosumab Injection In U.S.

June 9 (Reuters) - Luye Pharma Group Ltd:

* RECOMBINANT ANTI-RANKL FULLY HUMAN MONOCLONAL ANTIBODY INJECTION GOT APPROVAL FROM U.S. FDA TO INITIATE CLINICAL TRIALS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up